Abstract
Intracranial hemorrhage (ICH) associated with fetal/neonatal alloimmune thrombocytopenia (FNAIT) is attributed mainly to endothelial damage caused by binding of maternal anti-HPA-1a antibodies to the αvβ3 integrin on endothelial cells (ECs). We examined the effect of anti-HPA-1a antibodies on EC function using 2 EC lines from different vascular beds, HMVEC of dermal origin and hCMEC/D3 of cerebral origin. Anti-HPA-1a sera significantly increased apoptosis in both HMVEC and hCMEC/D3 cells and permeability in hCMEC/D3 cells only. This increase in both apoptosis and permeability was significantly inhibited by a monoclonal anti-β3 antibody (SZ21) binding to the HPA-1a epitope. Our results indicate that (1) maternal anti-HPA-1a antibodies impair EC function by increasing apoptosis and permeability and (2) ECs from different vascular beds vary in their susceptibility to pathological effects elicited by maternal anti-HPA-1a antibodies on EC permeability. Examination of maternal anti-HPA-1a antibodies for their effect on EC permeability may predict potential ICH associated with FNAIT.
References
1.
Bussel
JB
, Zabusky
MR
, Berkowitz
RL
, McFarland
JG
. Fetal alloimmune thrombocytopenia
. N Engl J Med
. 1997 Jul
;337
(1
):22
–6
. .2.
Newman
PJ
, Derbes
RS
, Aster
RH
. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIA, and are distinguishable by DNA typing
. J Clin Invest
. 1989 May
;83
(5
):1778
–81
. .3.
Sankaran
S
, Robinson
SE
. Immune thrombocytopenia and pregnancy
. Obstet Med
. 2011 Dec
;4
(4
):140
–6
. .4.
Michelson
AD
. Platelet function in the newborn
. Semin Thromb Hemost
. 1998
;24
(6
):507
–12
. .5.
Yougbare
I
, Lang
S
, Yang
H
, Chen
P
, Zhao
X
, Tai
WS
, Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage
. J Clin Invest
. 2015 Apr
;125
(4
):1545
–56
.6.
Bussel
JB
, Sola-Visner
M
. Current approaches to the evaluation and management of the fetus and neonate with immune thrombocytopenia
. Semin Perinatol
. 2009 Feb
;33
(1
):35
–42
. .7.
Loewenthal
R
, Rosenberg
N
, Kalt
R
, Dardik
R
, Landau
M
, Yahalom
V
, Compound heterozygosity of HLA-DRB3*01:01 and HLA-DRB4*01:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia
. Transfusion
. 2013 Feb
;53
(2
):344
–52
. .8.
Salomon
O
, Rosenberg
N
. Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia
. Br J Haematol
. 2013 Aug
;162
(3
):304
–12
. .9.
Tiller
H
, Kamphuis
MM
, Flodmark
O
, Papadogiannakis
N
, David
AL
, Sainio
S
, Fetal intracranial haemorrhages caused by fetal and neonatal alloimmune thrombocytopenia: an observational cohort study of 43 cases from an international multicentre registry
. BMJ Open
. 2013 Mar
;3
(3
):e002490
. .10.
Widiapradja
A
, Santro
T
, Basta
M
, Sobey
CG
, Manzanero
S
, Arumugam
TV
. Intravenous immunoglobulin (IVIg) provides protection against endothelial cell dysfunction and death in ischemic stroke
. Exp Trans Stroke Med
. 2014 Jun
;6
:7
. .11.
Kiefel
V
, Santoso
S
, Weisheit
M
, Müeller-Eckhardt
C
. Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies
. Blood
. 1987 Dec
;70
(6
):1722
–6
. .12.
Bayat
B
, Traum
A
, Berghöfer
H
, Werth
S
, Zhu
J
, Bein
G
, Current anti-HPA-1a standard antibodies react with the β3 integrin subunit but not with αIIbβ3 and αvβ3 complexes
. Thromb Haemost
. 2019 Nov
;119
(11
):1807
–15
. .13.
Fiore
M
, Bayat
B
, Phuangtham
R
, Blouin
L
, Huguenin
Y
, Bein
G
, Immunization against α IIb β 3 and α v β 3 in Glanzmann thrombasthenia patients carrying the French Gypsy mutation
. J Thromb Haemost
. 2021 Jan
;19
(1
):255
–61
. .14.
Soldi
R
, Mitola
S
, Strasly
M
, Defilippi
P
, Tarone
G
, Bussolino
F
. Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2
. EMBO J
. 1999 Feb
;18
(4
):882
–92
. .15.
Santoso
S
, Wihadmadyatami
H
, Bakchoul
T
, Werth
S
, Al-Fakhri
N
, Bein
G
, Antiendothelial αvβ3 antibodies are a major cause of intracranial bleeding in fetal/neonatal alloimmune thrombocytopenia
. Arterioscler Thromb Vasc Biol
. 2016 Aug
;36
(8
):1517
–24
. .16.
Alghisi
GC
, Ponsonnet
L
, Rüegg
C
. The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells
. PLoS One
. 2009
;4
(2
):e4449
. .17.
Bakchoul
T
, Greinacher
A
, Sachs
UJ
, Krautwurst
A
, Renz
H
, Harb
H
, Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia
. Blood
. 2013 Jul
;122
(3
):321
–7
.18.
Bakchoul
T
, Boylan
B
, Sachs
UJ
, Bein
G
, Ruan
C
, Santoso
S
, Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab′)2 in an in vivo mouse model of alloimmune thrombocytopenia
. Transfusion
. 2009 Feb
;49
(2
):265
–70
.© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
